Metabolic
PYY3-36
Also called Peptide YY(3-36)
per administration
A human trial worked out how much to take and how often, so a dosing schedule is shown.
The human evidence for PYY3-36 used the intravenous route. The draw worked out here assumes a subcutaneous injection, so the amount is not a direct read-across.
Quick start
PYY3-36 at a glance — the figures, plus how it's commonly run. Reference only, not medical advice.
- Typical dose
- 10–50 mcg per administration
- How often
- Every day
- Where
- Intravenous (clinical setting)
- Time to steady level
- ~1 hours — about five half-lives
- Storage
- Dry vial kept cold and dark; a mixed vial in the fridge at 2–8 °C. Details
A research and community reference, not medical advice. Figures are descriptive, vary between sources, and are not a recommendation for use.
Work out your draw
These numbers are a starting point — change any of them.
Vial label
Copy this into your label printer.
Published research contexts for PYY3-36 describe 10–50 mcg per administration. Descriptive only, not a recommendation.
Roughly 8–10 minutes; the decay chart is largely illustrative here.
A gut hormone and Y2 receptor agonist studied for reduced food intake. The human evidence used intravenous infusion (Batterham, Nature 2002 and NEJM 2003); no subcutaneous schedule is established, so no schedule table is shown.
Modelled level — every day
1× is the peak after a single dose.
- Steady-state peak
- 0.98× single dose
- Time to steady state
- 1hours
- Administrations
- 7/ week
Read off the modelled curve, not an even-interval formula
About five half-lives
Where these numbers come from
- Batterham RL et al., Nature 2002;418:650Intravenous PYY3-36 infusion reduced food intake in a controlled study of volunteers.
- Batterham RL et al., NEJM 2003;349:941Intravenous infusion lowered energy intake across lean and obese subjects; the route is infusion, not subcutaneous.